跳至主要内容
临床试验/CTRI/2024/04/066205
CTRI/2024/04/066205招募中4 期

Minimum effective dose of carbetocin during cesarean delivery in patients of preeclampsia with and without magnesium sulfate therapy: A sequential allocation dose-response study - NI

niversity College of Medical Sciences and GTBH0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Non-laboring parturients, with preeclampsia (with or without magnesium sulfate therapy scheduled for cesarean delivery under spinal block

排除标准

  • Patient refusal, presence of active labor (defined as cervical dilatation of 4 cm or more), preoperative use of oxytocin, or other conditions predisposing to PPH i.e., history of previous PPH, chorioamnionitis, macrosomia, more than two previous uterine surgery, previous history of bleeding disorders, and presence of abnormal placentation/uterine fibroid; as well as use of general anesthesia

研究者

发起方
niversity College of Medical Sciences and GTBH

相似试验